Vinson Amanda J, Thanamayooran Aran, Tennankore Karthik K, Foster Bethany J
Division of Nephrology, Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
Nova Scotia Health, Halifax, Nova Scotia, Canada.
Kidney Int Rep. 2024 Apr 25;9(7):2157-2167. doi: 10.1016/j.ekir.2024.04.039. eCollection 2024 Jul.
In the United States, women are less likely to be referred, activated on the waitlist, or undergo kidney transplant (KT) than men; contemporary Canadian data regarding access to transplant for women are lacking.
Among patients initiating dialysis in Nova Scotia (NS), Canada from 2010 to 2020, we examined the association of candidate gender with overall access to KT, including the following: (i) odds of transplant referral within 1 year of dialysis initiation, (ii) odds of activation on the transplant waitlist (if referred), and (iii) time-to-transplantation (if activated) using logistic regression or Cox proportional hazards models as appropriate.
Among 749 patients deemed potentially eligible for transplant, women had lower transplant rates than men (adjusted hazard ratio [aHR]: 0.53, 95% confidence interval [CI]: 0.36-0.78); this was amplified among patients aged >60 years (aHR: 0.25, 95% CI: 0.09-0.69). Compared with men, women had a lower adjusted odds of transplant referral (adjusted odds ratio [aOR]: 0.57, 95% CI: 0.35-0.93) by 1 year after dialysis initiation. Among those referred, women had lower odds of waitlist activation than men (aOR: 0.58, 95% CI: 0.30-1.11); and among those activated, women had lower hazard of KT (aHR: 0.74, 95% CI: 0.51-1.09), though these differences were not statistically significant. Women in NS experience lower overall access to transplant, including less referral, activation and KT compared with men.
Gender-based barriers to any of (or in this case each of) referral, activation, or transplantation result in inequities in access; identification of disparities at these critical decision points is an important first step toward ensuring equal access for all.
在美国,与男性相比,女性被转诊、进入等待名单或接受肾移植(KT)的可能性更低;目前缺乏关于加拿大女性获得移植机会的相关数据。
在2010年至2020年期间于加拿大新斯科舍省(NS)开始透析的患者中,我们研究了候选人性别与获得KT的总体机会之间的关联,包括以下方面:(i)透析开始后1年内被转诊进行移植的几率,(ii)进入移植等待名单(如果被转诊)的几率,以及(iii)移植时间(如果进入等待名单),根据情况使用逻辑回归或Cox比例风险模型。
在749名被认为有潜在移植资格的患者中,女性的移植率低于男性(调整后风险比[aHR]:0.53,95%置信区间[CI]:0.36 - 0.78);在60岁以上的患者中这种情况更为明显(aHR:0.25,95% CI:0.09 - 0.69)。与男性相比,女性在透析开始后1年被转诊进行移植的调整后几率较低(调整后优势比[aOR]:0.57,95% CI:0.35 - 0.93)。在那些被转诊的患者中,女性进入等待名单的几率低于男性(aOR:0.58,95% CI:0.30 - 1.11);而在那些进入等待名单的患者中,女性进行KT的风险较低(aHR:0.74,95% CI:0.51 - 1.09),不过这些差异无统计学意义。与男性相比,新斯科舍省的女性获得移植的总体机会较低,包括转诊、进入等待名单和进行KT的机会都更少。
转诊、进入等待名单或移植过程中基于性别的障碍导致了获得机会的不平等;在这些关键决策点识别差异是确保所有人获得平等机会的重要第一步。